Stay updated on Reirradiation With Pembrolizumab in Head-and-Neck Clinical Trial

Sign up to get notified when there's something new on the Reirradiation With Pembrolizumab in Head-and-Neck Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Reirradiation With Pembrolizumab in Head-and-Neck Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The study page now states that no participants are being sought, clarifying that recruitment is closed for this trial.
    Difference
    0.4%
    Check dated 2026-06-13T00:58:51.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision: v3.5.5 was added to the page, replacing the previous revision tag and signaling a new release of the study record. This metadata update does not modify the study details or eligibility information.
    Difference
    0.1%
    Check dated 2026-06-05T21:48:35.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.4, replacing the previous Revision: v3.5.3. This indicates a new version of the page/document has been released.
    Difference
    0.1%
    Check dated 2026-05-15T16:30:26.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    The page’s footer “Revision” number was updated from v3.5.2 to v3.5.3, indicating a site/backend version change rather than a change to the clinical trial record content.
    Difference
    0.1%
    Check dated 2026-04-24T05:21:13.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T21:36:07.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Added the disease category Squamous cell carcinoma of the head and neck and introduced a Resources section linking the Genetic and Rare Diseases Information Center.
    Difference
    0.2%
    Check dated 2026-04-02T15:11:21.000Z thumbnail image

Stay in the know with updates to Reirradiation With Pembrolizumab in Head-and-Neck Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Reirradiation With Pembrolizumab in Head-and-Neck Clinical Trial page.